US approves controversial new Alzheimer’s drug
Al Jazeera
New medicine made from living cells given by infusion reduces plaque on the brain, gives hope for sufferers.
United States health officials on Monday approved a new drug for Alzheimer’s disease – the first in nearly 20 years – giving hope to 6.2 million Americans and many more worldwide over the age of 65 who suffer from the brain disease. On Monday, the Food and Drug Administration (FDA) announced that it had granted approval to a drug called aducanumab for patients with Alzheimer’s disease. It is the only drug approved by US regulators to treat the underlying cause of the disease, the build-up of fatty plaque in the brain. Clinical trials of the new drug, developed by Biogen Inc, showed a reduction in the plaque, thus helping to slow mental decline.
Vulnerable nations are seeking $1.3 trillion annually to deal with the damage caused by climate change and to adapt.
The city’s southern suburbs have been hit repeatedly in recent months
New York judge cancels a sentencing hearing previously scheduled for November 26 without setting a new date.
Many Haitian children face the stark choice of joining a gang or suffering from violence, poverty and hunger engulfing them.
Tapped to lead the Justice Department, Bondi is a former Florida attorney general and longtime Trump supporter.
The arrest warrants against Netanyahu and Gallant could lead to countries rethinking arms deals with Israel, experts say
Moscow says the Oreshnik, a nuclear-capable weapon, was used in an attack on Ukraine amid escalating tensions.
Police say a ‘suspected prohibited item’ was discovered in luggage in the facility’s south terminal.
The NGOs want the Netherlands to ban the export and transit of weapons, weapon parts, and dual-use items to Israel.
All the details about the biggest two weeks in chess as a young Indian grandmaster takes on the Chinese world champion.
South Korea’s national security adviser says North plans to use the weapons to defend its airspace over the capital.